Andrew Lynn is an entrepreneur and executive with a focus on life-science and physical-science ventures. Andrew founded Orthomimetics, a regenerative orthopaedic devices company, based on his PhD research conducted jointly at the University of Cambridge and the Massachusetts Institute of Technology.
He led Orthomimetics as CEO from incorporation to acquisition, establishing commercial-scale manufacturing capabilities, bringing the company’s flagship product through pilot clinical trials to market and leading a process that culminated in a successful trade-sale exit in 2009. Dr Lynn subsequently led solid-state-lighting venture CamGaN Limited as CEO from the commencement of operations to the company’s acquisition in 2012. His efforts have earned him recognition in Europe as an inaugural winner of a Science|Business Academic Enterprise Award and in the US as a member of Technology Review Magazine’s TR35 list of the world’s top young innovators, leaders and entrepreneurs.